Brenda Fallas Selected Research

Bevacizumab (Avastin)

1/2019

Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brenda Fallas Research Topics

Disease

2	Cysts 09/2021 - 01/2018
2	Retinal Detachment (Retinal Detachments) 09/2021 - 01/2017
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2021
1	Endophthalmitis (Ophthalmia) 06/2020
1	Pre-Eclampsia (Preeclampsia) 06/2020
1	Cavernous Hemangioma (Cavernous Angioma) 01/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2019
1	Retinal Hemorrhage 10/2019
1	Incontinentia Pigmenti (Bloch Sulzberger Syndrome) 01/2019
1	Cysticercosis 01/2018
1	Achondroplasia 01/2017

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 01/2020 - 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	Bevacizumab (Avastin)FDA Link 01/2019

Therapy/Procedure

1	Anesthesia 09/2021
1	Therapeutics 06/2020
1	Cesarean Section (Caesarean Section) 06/2020
1	Laser Therapy (Surgery, Laser) 01/2019
1	Vitrectomy 01/2018